Replies to post #557369 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

BTW, the latest PR seems to suggest NWBO is holding onto the company for post MAA PIP set up, more post 1B Sawston expansion and Flaskwork’s version selection. So they plan to stick around for a while longer it appears.

[beartrap12]

Flipper, thanks for pointing out the lineup between everything going on in the NWBO sphere, including manufacturing and submissions to NICE. I know you’ve kept a close eye on NICE submissions and I’m hoping you’re right!
I also noticed that management’s comments on setting up the PIP trial and continuing work at expanding Sawston points to them staying in business for a while.

Flipper:

If you take the new STA 2022 protocol NWBO started under with NICE on December 23, 2022. If you count that as week “0”, week 8, when an evidence submission is due under the general STA timeline, would be February 17, 2023. (Kinda funny how they exited the 2018 STA and entered the 2022 STA without people noticing because of the kerfuffle.)

Kinda matches up with the scanning countdown, plus a cushion to add the latest (MIA) prerequisite material? Maybe simultaneous submissions? MAA and NICE?

Also matches up with NICE saying they expect the next contact from NWBO early in 2023.